Concomitantly, NK cell dysfunction in chronic myelogenous leukemia (CML) is likely to be caused by tumor-produced ROS, since NK cell cytotoxic capacity against primary tumor cells obtained from patients affected with this malignancy was restored in the presence of catalase [62]. The gene discussed is CAT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.